Stay updated with breaking news from Albertd Friedberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 1/2a SIGNAL-AD Study of Pepinemab in Alzheimer’s Disease Achieves Full Accrual Expect to Complete 12-months treatment in June, 2024 Promising Interim Results for KEYNOTE-B84 Phase 2 Trial... -Today at 08:11 am- MarketScreener
Phase 1/2a SIGNAL-AD Study of Pepinemab in Alzheimer's Disease Achieves Full Accrual Expect to Complete 12-months treatment in June, 2024 Promising Interim Results for KEYNOTE-B84 Phase 2 Trial in Head and Neck Cancer
Significant YTD Progress in Neurology and Oncology Programs New financing of $5MM closed without warrants, derivatives or other financial considerations ROCHESTER, N.Y., May 15, 2023 -- Vaccinex,... | May 15, 2023
ROCHESTER, N.Y., April 03, 2023 -- Vaccinex, Inc. , a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the... | April 3, 2023
Get email notification for articles from David B. Green Follow Apr. 29, 2021 6:55 PM In 1970, Israel Adler, then the director of Israel’s Jewish National and University Library, visited the Paris home of Rachel Mosseri, a Jewish exile from Nasser’s Egypt. Adler had a big mission, and limited time to carry it out – just 10 days to catalog and photograph the roughly 7,000 documents from the Cairo Genizah that constituted the collection assembled by Mosseri’s late husband, Jacques Mosseri, some six decades earlier. From other caches, most notably that assembled by Solomon Schechter, the...